Background: Methicillin Resistant Staphylococcus aureus (MRSA) is a common source of nosocomial infection, which is spreading through the community and hospitals across the countries. The performance of screening program really needs major effort related to laboratory capacity and ethical consideration, among other costly components. Significant literature research was conducted to review the cost, effectiveness and practicality of diffe rent methods of preadmission MRSA screening in the hospital setting. A systematic literature review was conducted with search strategy using the PubMed Medline, Scopus and the Science Direct databases. The relevant data was abstracted from all studies based on various countries which in line with the finalized eligibility criteria. Results: PCR method was reported to have high sensitivity with low turnaround time as compared to culture method. A review of selected studies found the increasing annual costs of screening from standard culture, chromogenic agar to rapid PCR. In the meantime, other studies reported the total costs for labor and materials was lower for rapid PCR screening compared to culture methods. The culturing method offers a high level of variability due to time consumption and additional costs. Whereas PCR was reported as advantageous in term of saving time to identify MRSA positive patients, which involved isolation, thus increase the effectiveness of screening programs. It can pick up false negative results by conventional methods in the early condition of disease. Conclusion: Most studies verified that PCR is the most accurate method for detection of MRSA with Xpert MRSA having the best performance. Otherwise, oxacillin agar screen was revealed as a good alternative method to PCR. Targeted screening on high risk patients using rapid PCR may be the best choice to be implemented, in order to balance the economic and practicality of screening. We recommend that further clinical studies should be done to provide a sharp evidence of MRSA screening. Previous studies have shown that ineffective antimicrobial therapy will lead to excess mortality and significantly prolonged hospitalization. [4] [5] [6] Hospital acquired infections increases morbidity, mortality and health care costs.
INTRODUCTION
A common source of nosocomial infection is spreading through the community and hospitals across the countries. 1, 2 This particular of superbug is called Methicillin Resistant Staphylococcus aureus (MRSA) has been found in the nose, throat, axillae, groin and perineum of a person, in surgical patients and patients with a catheter and intravenous lines. 3 Previous studies have shown that ineffective antimicrobial therapy will lead to excess mortality and significantly prolonged hospitalization. [4] [5] [6] Hospital acquired infections increases morbidity, mortality and health care costs. 7 There was a little research regarding the cost implications of implementing MRSA screening programs. [8] [9] [10] [11] The performance of screening program really needs major effort related to laboratory capacity and ethical consideration, among other costly components. 12 Though some studies find ambiguous effects of MRSA infection, these findings may provide useful answers in balancing the potential economic costs and benefits of pre-admission screening as one of the control measures. Selected parameters that are considered to be significant are summarized. A selection of these factors is identified as an overview using a systematic literature research. The objective of this study is to review the cost and effectiveness of different methods of pre-admission MRSA screening with respect to the cost, practical and ethical issues concerning the screening to be implemented in Malaysia. This study was conducted in particular to review in hospitals setting and to find possible solutions to potential problems that may arise from the implementation of the MRSA screening. This study aims to bring up adequate evidence-based information on the cost and effectiveness of the testing.
PCR methods were Xpert MRSA assay with 75% and Quantitative PCR with 91%. 12, 43, 44 According to another study "PCR for mecA gene is the best method for detecting methicillin resistance in S. aureus with respect to accuracy, sensitivity, specificity, speed, and cost effectiveness". 37 
Costs Effectiveness
Overall costs regarding MRSA screening were abstracted from selected studies and represented (Table 4) . Generally, the average costs for each study were different resulting from international settings, which based on wide-ranging currencies, exchange rates, years of investigations, the total mean of patients monthly or annually and different methods employed. Cost evaluations of conventional methods and rapid PCR were focused in this systematic review. Based on one study, annual costs of MRSA screening were increasing from standard culture, chromogenic agar to rapid PCR, which were US$126,788 (RM388,562.24), US$135,906 (RM416,505.81) and US$192,709 (RM590,587.75), respectively. 35 The total of expenses includes laboratory supplies, laboratory technician time, nurse collection time, costs per test, variable costs of tests overhead and management. The expected costs of the intervention per admitted hospital patient were also increased from standard culture, chromogenic agar to rapid PCR, which were $22.22 (RM68.10), $23.33 (RM71.50) and $30.20 (RM92.55). 35 Another study reported that the cost of preventing one MRSA infection by introducing conventional culture screening policy was measured to be £3200 (RM20,818.44) in England with additional costs that achieved £13 972 (RM90,898.53) per patient to treat MRSA infection. 34 The other requirements involved the costs of the length of prolonged admission. 34 One more study calculated the total costs of labor and materials was lower for rapid PCR screening with cost of US$3.74 (RM12.37), compared to conventional culture methods which cost US$4.90 (RM16. 20) for oxacillin disk diffusion, US$13.76 (RM45.50) for E-tests oxacillin and US$5.91 (RM19.54) for MRSA screen latex. 14 The cost avoidance of unnecessary isolation of US$108,940.08/year (RM357,216.98) was obtained with total annual cost savings of US$101,230.21 (RM331,936.14) resulting from screening program implementation. Screening of all admissions would become cost-effective if at least a quarter of patients screened were MRSA-positive. 45 Implementation of MRSA screening by automated PCR was estimated to save a total of €7.3 million (RM13,897,000.98) in hospital costs for patients over the years 2006 to 2009. 47 Another research investigated the costs of targeted screening in high risk units using rapid PCR and identified that monthly costs of screening program was US$3,475 (RM13,132.95). 17 They found the cost avoidance of $19,714/month (RM74,504.45) for ICUs after implementation of screening. 17 Meanwhile, an alternative study suggested targeted screening using conventional culture screening program with the annual cost of €10261 (RM274.95). 22 The economic burden caused by MRSA infections achieved €101,000/year (RM2,706.34) with the mean estimated the cost of a single infection of €2730 (RM73.16). The costs include the infection control nursing (infection control nursing for patients screened and visits to patients in isolation), screening and follow-up cultures, isolation and decolonization procedures (staff contacts with gloves and gown). 22 A review study explored that universal MRSA screening strategies are far expensive than the targeted screening approaches. But, all targeted screening strategies turn out lower costs than not performing a screening at all. 42 The same outcome was also determined by another study stated that screening all patients at high risk units and those previously detected with MRSA or screening of flagged patients only bring the cost effectiveness in hospital viewpoint. Methicillin-resistant Staphylococcus aureus on orthopaedic wards The cost of care for such patients greatly exceeds the cost of introducing a policy to prevent MRSA infection. Introducing a surveillance and treatment policy is a cost-effective way of reducing its incidence.
Nyman et al, 2011 35 Cost of screening intensive care unit patients for methicillinresistant Staphylococcus aureus in hospitals The intervention was cost saving compared with no intervention. Because of the high cost of caring for a MRSA patient, interventions that reduce the spread of infections-such as screening intensive care unit patients upon admission studied here-are likely to pay for themselves.
Ornskov et al., 2008 36
Screening for methicillin-resistant Staphylococcus aureus in clinical swabs using a high-throughput real-time PCR-based method Semi-automated, high throughput, real-time PCR-based screening method for MRSA has good reproducibility, 100% sensitivity and high specificity. Transmission rates, screening methods and costs of MRSA-a systematic literature review related to the prevalence in Germany PCR methods show a higher sensitivity and specificity than the culture methods, which exhibit more statistical spread. Furthermore, a much faster turn-around time of PCR methods was detected, so test results are available within a day. This is balanced by the higher costs. In active-surveillance convenience sample, the use of broth enrichment followed by subculture to MS offered a low-cost but sensitive method for MRSA screening, with performance similar to that of Xpert MRSA PCR.
tive patients, which involved isolation, thus increase the effectiveness of screening programs. 33 PCR can pick up false negative results by conventional methods in the early condition of the disease. It could accurately detect the presence of mecA gene rapidly with only 5 hours of bacterial isolation. Whereas, the time taken in diagnosing MRSA by the conventional method is 48-72 hours, which is twice longer than PCR method. 37 In order to identify the best solution that leads to cost benefit in terms of practicality and ethicality, an MRSA screening program should be reevaluated by the DOH. The MRSA screening program should accomplish the ideal screening criteria set out by Wilson and Junger (WHO 1968) . 15 The University Hospitals of Leicester NHS Trust develop MRSA policy in October 2003 to manage and reduce the increasing incidence of MRSA among trauma patients. The plans involved deep cleaning of wards, staff education program and providing alcohol gel dispensers in each patient's bed. 34 Moreover, screening swabs should be taken from multiple sites in order to enhance the performance. PCR was reported to have a tendency to yield false-positive rates compared to culture method. Due to this, quality assurance systems should be taken to maintain the reliability of results. 21 A research found that almost half percentage patients that were admitted to MRSA contact isolation did not favor the isolation and quarter of them resulting in having emotional distress. 25 In order to improve patients experience and reduce costs, their studies suggested that screening with isolation should be done by targeting patients with a history of MRSA only. Several responses were recorded from patients, included feeling contaminated, inconvenient and uncomfortable. Patients that suffer emotional distress believe that isolation disturbed the privacy, and their rights were limited. In addition, some of them find that they have different treats from nurses and fewer visitors because of the gap restriction, which increase the level of uncertainty of their MRSA status.
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DISCUSSION
The practicality and cost effectiveness of different MRSA screening methods have become an extended debate in the medical area. The emergence of technology, conventional methods were mostly replaced by rapid screening PCR. However, the traditional method was still preferred in the first place for certain area worldwide. The main causes of the debate include the accuracy, turnaround time, cost per test, overall costs and workforce availability. Another study found that the high cost of PCR can be neutralized and cost effective in higher prevalence settings of MRSA. 12 The cost of workload per PCR can be decreased by increasing the daily number of MRSA screening tests. Even the whole costs for PCR greatly exceed the cost of the conventional method; it is revealed as the best option. 37 PCR methods were said to have excellent sensitivity and specificity with minimum time to obtain results of 2 hours. Alternatively, conventional method maintained popularity as it offers, lower costs compared to PCR. Direct agar cultures were reported as relatively insensitive in comparison to PCR. Broth enrichment cultures were required to improve sensitivity. [48] [49] [50] [51] Another study suggested that the addition of enrichment culture for culture method. 64 In the meantime, advancement would lead the increasing of TAT, while a PCR method was able to perform well without enrichment or any extraction. 65, 66 Most studies verified that PCR is the most accurate method for detection of MRSA. [52] [53] [54] [55] [56] Otherwise, oxacillin agar screen was revealed as a good alternative method to PCR. It was proved to have high sensitivity and specificity for detection of MRSA with reasonable economic reasons. The results were confirmed with those of other studies that used the presence of the mecA gene as the "gold standard'' . 3, 13, 15, 20, 22, 29, 33 Any laboratory performing tests for MRSA needs to weigh up the patient benefit in relation to MRSA prevalence and the advantage of rapid results". 20 Another research stressed that two parameters which must be taken seri- ously to choose the reasonable screening strategy were MRSA prevalence and rate of MRSA of transmission per day of non-isolated patients. 42 Transmission rates of MRSA were reported to be higher in isolation compared to vice versa. "The costs that carried by isolation include personnel protective equipment for workers and visitors (extra gowns, gloves, masks, and caps, cleaning costs and time for nurses and physicians attributable to isolation precautions)". 41 "The use of PCR resulting in a reduction of a median 4 isolation days per patient, which directly reduce costs for previous MRSA carriers that tested positive at readmission". 43 In this new era, quality of time has been a high demand. PCR method was said to have clear boundaries compared to culture methods with the advancement of turnaround time which balanced the high costs. The number of inappropriate isolation days (nursed patients under MRSA precautions, but were not MRSA positive on admission) was lower in rapid screening PCR compared to culture method. Whereas, the inappropriate open days (patients not under MRSA precautions, but MRSA positive on admission) were also lower for PCR compared to conventional method. 67 Xpert MRSA was said to have the best performance, which reduces isolation hours, followed by BD Gene Ohm MRSA and doubled duration with chromogenic agar (30 hours versus 16.1 hours). 44 Our systematic review consists of several limitations. First, the costs were varied for different studies. Some studies were limited to direct costs and indirect costs. Several studies calculate costs based on annual and monthly costs, which involved different scopes of patients. Studies from a wide-ranging countries provide different perceptions in analyzing costs. Second, the selection of studies was conducted independently, which include different qualities. Publication bias might occur due to a large number of poor quality studies. However, the studies were already filtered with some stages in order to maintain the reliability of this review. Indeed, the costs of MRSA screening using PCR are much higher than the costs of traditional culture. However, the higher costs clearly outweigh the clinical and economic benefits of saving time. 47 The outcome and effectiveness of MRSA screening from several studies were clearly summarized (Table 5 ). Based on the holistic review, our findings provide that PCR offers an excellent package of maintaining high sensitivity and specificity throughout the process, with lower turnaround time and isolation days. As a conclusion, targeted screening using rapid PCR may be the best choice to be implemented in Malaysia. The targeted screening of high-risk patients is a good strategy in order to balance the economic and practicality of testing due to demand for cost effectiveness. This research recommends that further clinical studies should be done in Malaysia, to provide a definite evidence of MRSA screening.
CONCLUSION
As a conclusion, targeted screening using rapid PCR may be the best choice to be implemented in the hospital setting. Due to the demand of cost effective, targeted screening of high risk patients is a good strategy in order to balance the economic and practical of screening. We recommend that further clinical studies should be done to provide a sharp evidence of MRSA screening.
